FILTER
FILTERED INTERVIEW RESULTS
Trevor Caswell
CHAIRMAN, PHARMA.AERO
"We now offer an open platform for life sciences companies to have conversations around priorities in their field and discuss challenges in the supply chain."
Anwar Daud
MANAGING DIRECTOR, ZIM LABORATORIES
"We progressed on the development of our New Innovative Products (NIP), which are complex generics developed using in-house proprietary technology platforms."
Daniel Prince
CEO, PRINCE STERILIZATION SERVICES
"We are extremely excited about the growth our hydrogen peroxide and packaging segments can bring."
Joe Panetta
PRESIDENT AND CEO, BIOCOM CALIFORNIA
"We are beginning to see California move forward as not two or three individual clusters, but rather as a powerhouse of integrated clusters, and this will continue to be our focus in the future."
Kendalle Burlin O’Connell
CEO AND PRESIDENT, MASSBIO
"In 2023, Massachusetts made up just shy of 15% of the national drug development pipeline and approximately 7% of the global drug development pipeline."
Andrea Confetti and Roberto Fanelli
EXCLUSIVE SYNTHESIS BU LEADER (AC) & CATALOGUE APIS BU LEADER (RF), DIPHARMA FRANCIS
"The FDA approved 55 new drugs in 2023, of which 34 were small molecules, which is an over 50% increase compared to 2022. This opens new opportunities for Dipharma in the years to come."
Trevor P. Castor
PRESIDENT & CEO, APHIOS
"Aphios, which means virus-free, has the core mission to not only contain viruses but also to treat underlying infectious diseases."
Milton Boyer & David Stevens
CEO (MB) & CCO (DS), KINDEVA DRUG DELIVERY
"A shift in pharma’s pipeline catalyzes a need for changes to CDMOs’ capacity."
Paolo Paissoni
DIRECTOR OF INNOVATION AND BUSINESS DEVELOPMENT, PROCOS SPA
"We are currently building a new workshop in which we are specifically going to add small-scale lines to support clinical trial supply and generic product manufacturing."
Louis P. Kassa III
PRESIDENT AND CEO, PENNSYLVANIA BIOTECHNOLOGY CENTER (PABC)
"We want scientists to focus on science, and we offer them the equipment and services so they can do that."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Mexico Chemicals 2024
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
